Geographical Distribution of COVID-19 Confirmed Cases in Iran: A Short Communication

Document Type : Brief Communication

Authors
1 Department of Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, IR, Iran
2 Vector-Borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran
3 Medical Informatics Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Background: In Iran, the first cases of SARS-CoV-2 disease were detected with the death of 2 people in Qom city. Then other cases were reported in Markazi, Tehran, and Gilan provinces, and after that the disease spread to all 31 provinces of the country.

Materials and Methods: All data used in this study were collected from the reports of the National Committee on COVID-19 Epidemiology in the Ministry of Health and Medical Education in Iran. To investigate the effect of traveling between neighboring provinces, a spatial rate smoothing method was used, showing the impact of neighborhood on the disease prevalence. Also, to investigate the relationship between population density and disease prevalence, spatial regression was used at a significance level of 5%.

Findings: Based on the estimated spatial rates, the disease prevalence rates changed in many provinces compared to the raw prevalence rates. Population density was also found to be directly related to the disease prevalence, so that with increasing population density, the disease prevalence rate increased (p <.001).

Conclusion: It seems that case finding process should be done actively in all provinces of Iran regardless of administrative borders. Provinces should also be classified in terms of the disease transmission risk according to population density of patients, which may indicate the probability of contact between individuals.

Keywords


1. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020;9(1):1-12.
2. WHO. WHO Coronavirus Disease (COVID-19) Dashboard: World Health Organization; 2020 [Available from: https://covid19.who.int/.
3. Taheri Soodejani M, Lotfi MH, Tabatabaei SM. Is case fatality rate an appropriate index to represent the status of case-finding process for COVID-19 in different countries? Infection Ecology & Epidemiology. 2020;10(1):1773733.
4. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Mapping the incidence of the COVID-19 hotspot in Iran–Implications for Travellers. Travel medicine and infectious disease. 2020.
5. Taheri Soodejani M, Tabatabaei SM, Dehghani A, McFarland W, Sharifi H. Impact of Mass Screening on the Number of Confirmed Cases, Recovered Cases, and Deaths Due to COVID-19 in Iran: An Interrupted Time Series Analysis. Arch Iran Med. 2020;23(11):776-81.
6. MoHME). orona statistics in IRAN: Ministry of Health and Medical Education(MoHME); 2020 [Available from: corona.behdasht.gov.ir/files/site1/files/Factsheet8.03.01-Fa-N.pdf.
7. Goovaerts P. Geostatistical analysis of disease data: estimation of cancer mortality risk from empirical frequencies using Poisson kriging. International journal of health geographics. 2005;4(1):31.
8. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020.
9. Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science (New York, NY). 2020.
10. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of travel medicine. 2020.
11. Rocklöv J, Sjödin H. High population densities catalyze the spread of COVID-19. Journal of travel medicine. 2020.